Company Filing History:
Years Active: 2001-2002
Title: Gerd Maass: Innovator in AAV Vector Technology
Introduction
Gerd Maass is a prominent inventor based in Sindelsdorf, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of adeno-associated virus (AAV) vector systems. With a total of 3 patents, his work has advanced the understanding and application of gene therapy.
Latest Patents
One of Gerd Maass's latest patents is titled "Recombinant AAV vector-based transduction system and use of same." This invention relates to a transduction system that includes a rep-negative AAV vector containing foreign DNA and a product providing an AAV Rep protein. The patent also covers the use of this innovative transduction system. Another notable patent is "System for the production of AAV vectors," which further enhances the capabilities of AAV technology.
Career Highlights
Gerd Maass is currently associated with Medigene AG, a company known for its pioneering work in immunotherapy and gene therapy. His role at Medigene AG has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of Gerd Maass's notable coworkers include Christoph Bogedain and Michael Hallek. Their collaborative efforts have played a crucial role in advancing the research and development of AAV vector technologies.
Conclusion
Gerd Maass is a key figure in the field of biotechnology, with a focus on AAV vector systems. His innovative patents and contributions to Medigene AG highlight his commitment to advancing gene therapy. His work continues to influence the future of medical research and treatment options.